J. D. Souza

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

J. Rosenstock, R. Heine, S. Kahn, 2021, The Lancet.

CARE MANAGEMENT FOR PATIENTS WITH VENOUS ULCERS* GERENCIAMENTO DO CUIDADO AOS PACIENTES COM ÚLCERAS VENOSAS GESTIÓN DEL CUIDADO A LOS PACIENTES CON ÚLCERAS VENOSAS

Z. Silvino, C. M. Balbino, J. D. Souza, 2019 .